Press release
Primary Open Angle Glaucoma (POAG) Pipeline Analysis (2023) Covering Clinical Trials, Emerging Therapies, FDA, EMA, and PMDA Approvals, Competitive Landscape | Santen, PH PHARMA, Whitecap Biosciences, Ocular Therapeutix, TheratOcular Biotek
"Primary Open Angle Glaucoma (POAG) Pipeline Insight, 2023" report by DelveInsight provides a comprehensive analysis of the ongoing clinical development activities and growth prospects across the Primary Open Angle Glaucoma Therapeutics Market.
The report provides a detailed description of the Primary Open Angle Glaucoma drugs, including the mechanism of action, type, stage, route of administration, molecule type, clinical studies, inactive pipeline products, and NDA approvals (if any). The report also covers commercial and clinical activities of the pipeline products from the pre-clinical developmental phase to the marketed stage. Additionally, it presents the ongoing developments in the therapeutics segment, including collaborations, licensing, mergers & acquisitions (M&A), funding, designations, and other product-related details.
Get a Detailed Overview of the Primary Open Angle Glaucoma Clinical Trial Activities and Regulatory Developments in the domain @
https://www.delveinsight.com/report-store/primary-open-angle-glaucoma-poag-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rpr
Primary Open Angle Glaucoma (POAG) Pipeline Analysis
The report provides insights into:
• The report provides detailed insights into the key companies that are developing Primary Open Angle Glaucoma therapies.
• The report also evaluates different therapeutic candidates segmented into early-stage, mid-stage, and late-stage of development for Primary Open Angle Glaucoma treatment.
• It analyzes the key companies involved in targeted therapeutics development with respective active and inactive (dormant or discontinued) projects.
• It navigates the emerging Primary Open Angle Glaucoma drugs under development based on the stage of development, route of administration, target receptor, monotherapy or combination therapy, a different mechanism of action, and molecular type.
• Detailed analysis of collaborations (company-company collaborations and company-academia collaborations), licensing agreement, and financing details for future advancement in the Primary Open Angle Glaucoma treatment market.
Learn More about the Clinical and Commercial Development Activities in the Primary Open Angle Glaucoma Therapeutics Domain @
https://www.delveinsight.com/report-store/primary-open-angle-glaucoma-poag-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rpr
Primary Open Angle Glaucoma (POAG) Therapeutics Analysis
There are approx. 8+ key companies developing the therapies for Primary Open Angle Glaucoma. Currently, Deerland Probiotics & Enzymes is leading the therapeutics market with its Primary Open Angle Glaucoma drug candidates in the most advanced stage of clinical development.
Primary Open Angle Glaucoma Companies in the Therapeutics Market Include:
• Santen Pharmaceutical Co., Ltd.
• PH PHARMA CO. LTD.
• Whitecap Biosciences, LLC
• Ocular Therapeutix, Inc.
• TheratOcular Biotek Co., Ltd.
And Many Others
Emerging and Marketed Primary Open Angle Glaucoma Therapies Covered in the Report Include:
• STN1012600: Santen Pharmaceutical Co., Ltd.
• TO-O-1001: TheratOcular Biotek Co., Ltd.
And Many More
Get an in-depth Assessment of the Emerging Therapies and Primary Open Angle Glaucoma Companies Actively Working in the Market @
https://www.delveinsight.com/sample-request/primary-open-angle-glaucoma-poag-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rpr
The Report Covers the Emerging Primary Open Angle Glaucoma Therapies Under Different Phases of Clinical Development Like -
• Late-stage products (Phase III)
• Mid-stage products (Phase II)
• Early-stage product (Phase I)
• Pre-clinical and Discovery stage candidates
• Discontinued and inactive candidates
Route of Administration
Primary Open Angle Glaucoma pipeline report provides the therapeutic assessment of the pipeline drugs by the Route of Administration. Products have been categorized under various ROAs such as
• Intra-articular
• Intraocular
• Intrathecal
• Intravenous
• Ophthalmic
• Oral
• Parenteral
• Subcutaneous
• Topical
• Transdermal
Molecule Type
Products have been categorized under various Molecule types such as
• Oligonucleotide
• Peptide
• Small molecule
Request for Sample PDF to Understand More About the Primary Open Angle Glaucoma Treatment Outlook and Future Perspectives @
https://www.delveinsight.com/sample-request/primary-open-angle-glaucoma-poag-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rpr
Table of Content
1. Report Introduction
2. Executive Summary
3. Primary Open Angle Glaucoma Current Treatment Patterns
4. Primary Open Angle Glaucoma - DelveInsight's Analytical Perspective
5. Therapeutic Assessment
6. Primary Open Angle Glaucoma Late-Stage Products (Phase-III)
7. Primary Open Angle Glaucoma Mid-Stage Products (Phase-II)
8. Early Stage Products (Phase-I)
9. Pre-clinical Products and Discovery Stage Products
10. Inactive Products
11. Dormant Products
12. Primary Open Angle Glaucoma Discontinued Products
13. Primary Open Angle Glaucoma Product Profiles
14. Primary Open Angle Glaucoma Companies
15. Primary Open Angle Glaucoma Drugs
16. Dormant and Discontinued Products
17. Primary Open Angle Glaucoma Unmet Needs
18. Primary Open Angle Glaucoma Future Perspectives
19. Primary Open Angle Glaucoma Analyst Review
20. Appendix
21. Report Methodology
Get Detailed Insights About the Reports Offerings @
https://www.delveinsight.com/sample-request/primary-open-angle-glaucoma-poag-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rpr
------------------------------------------------------------------------------------------------------------------------------
Discover DelveInsight's Comprehensive Market Research and Consulting Services:
https://www.delveinsight.com/market-research
Elevate your industry insights with our comprehensive medical devices market assessment reports. Visit to gain a strategic edge through expert analysis and in-depth coverage of the latest trends, innovations, and market dynamics, at:
https://www.delveinsight.com/medical-devices
Empowering Cancer Care: DelveInsight's oncology consulting services offer personalized guidance and cutting-edge expertise to navigate the ongoing clinical, commercial, and regulatory developments, visit for more details:
https://www.delveinsight.com/oncology
Other Trending Healthcare Reports by DelveInsight
Acute Ocular Pain Market
https://www.delveinsight.com/report-store/acute-ocular-pain-market
Acute On Chronic Liver Failure (ACLF) Market
https://www.delveinsight.com/report-store/acute-on-chronic-liver-failure-aclf-market
Antibody-Mediated Graft Rejection Market
https://www.delveinsight.com/report-store/antibody-mediated-graft-rejection-market
Bacterial (Pyogenic) Meningitis Market
https://www.delveinsight.com/report-store/bacterial-pyogenic-meningitis-market
Bevacizumab Biosimilars
https://www.delveinsight.com/report-store/bevacizumab-biosimilars-insight
Bronchial Neoplasm Market
https://www.delveinsight.com/report-store/bronchial-neoplasm-market
Calcinosis Cutis Market
https://www.delveinsight.com/report-store/calcinosis-cutis-market
Cardiovascular Calcification Market
https://www.delveinsight.com/report-store/cardiovascular-calcification-market
Dermal Regeneration Matrix Market
https://www.delveinsight.com/report-store/dermal-regeneration-matrix-market
Epstein Barr virus (EBV) Market
https://www.delveinsight.com/report-store/epstein-barr-virus-ebv-market
Glabellar Frown Lines Market
https://www.delveinsight.com/report-store/glabellar-frown-lines-market
Goitre Market
https://www.delveinsight.com/report-store/goitre-market
Hereditary Deafness Medical Device Market
https://www.delveinsight.com/report-store/hereditary-deafness-medical-devices-market
ICOS-Next Generation Immunotherapy Market
https://www.delveinsight.com/report-store/icos-next-generation-immunotherapy-competitive-landscape
Metrorrhagia Market
https://www.delveinsight.com/report-store/metrorrhagia-market
Nephrosclerosis Market
https://www.delveinsight.com/report-store/nephrosclerosis-market
Parkinson's Disease Related Dementia Market
https://www.delveinsight.com/report-store/parkinsons-disease-related-dementia-market
Peripherally Inserted Central Catheter (PICC) Devices Market
https://www.delveinsight.com/report-store/peripherally-inserted-central-catheter-picc-devices-market
Severe Toxicities in Lymphoma Market
https://www.delveinsight.com/report-store/severe-toxicities-in-lymphoma
Single Ventricle Heart Disease Market
https://www.delveinsight.com/report-store/single-ventricle-heart-disease-market
Small Fiber Neuropathy Market
https://www.delveinsight.com/report-store/small-fiber-neuropathy-market
Stuttering Market
https://www.delveinsight.com/report-store/stuttering-market
Venous Stenosis Market
https://www.delveinsight.com/report-store/venous-stenosis-market
Hyperopia Market
https://www.delveinsight.com/report-store/hyperopia-market
Microvascular Angina Market
https://www.delveinsight.com/report-store/microvascular-angina-market
Progressive Familial Intrahepatic Cholestasis Market
https://www.delveinsight.com/report-store/progressive-familial-intrahepatic-cholestasis-pfic-market
CRISPR Therapies Pipeline Insight
https://www.delveinsight.com/report-store/crispr-therapies-pipeline-insight
Endometrial Hyperplasia Market
https://www.delveinsight.com/report-store/endometrial-hyperplasia-market
Adenoid Cystic Carcinoma Market
https://www.delveinsight.com/report-store/adenoid-cystic-carcinom-market
Chronic Pain Associated with Painful Diabetic Neuropathy Market
https://www.delveinsight.com/report-store/chronic-pain-associated-with-painful-diabetic-neuropathy-market
Contact Dermatitis Market
https://www.delveinsight.com/report-store/contact-dermatitis-market
Dermal Mycosis Market
https://www.delveinsight.com/report-store/dermal-mycosis-market
High-Grade Glioma Market
https://www.delveinsight.com/report-store/high-grade-glioma-hgg-market
Lymphatic Malformations Market
https://www.delveinsight.com/report-store/lymphatic-malformations-market
Nocturnal Enuresis Market
https://www.delveinsight.com/report-store/nocturnal-enuresis-market
Ulcer Haemorrhage Market
https://www.delveinsight.com/report-store/ulcer-haemorrhage-market
Adult-onset Still Disease Market
https://www.delveinsight.com/report-store/adult-onset-still-disease-market
Alcohol Use Disorder (AUD) Market
https://www.delveinsight.com/report-store/alcohol-use-disorder-market
Cell And Gene Therapy For Multiple Myeloma Market
https://www.delveinsight.com/report-store/cell-and-gene-therapy-for-multiple-myeloma-market
Chronic Pancreatitis (CP) Market
https://www.delveinsight.com/report-store/chronic-pancreatitis-market
Cough in Idiopathic Pulmonary Fibrosis (IPF) Market
https://www.delveinsight.com/report-store/cough-in-idiopathic-pulmonary-fibrosis-ipf-market
End-Stage Coronary Artery Disease Market
https://www.delveinsight.com/report-store/end-stage-coronary-artery-disease-market
Frontotemporal Dementia Market
https://www.delveinsight.com/report-store/frontotemporal-dementia-market
Cell and Gene Therapies in Rare Disorders Market
https://www.delveinsight.com/report-store/gene-and-cell-therapies-in-rare-disorder-market
Glycogen Storage Disease Market
https://www.delveinsight.com/report-store/glycogen-storage-disease-market
Maple Syrup Urine Disease Market
https://www.delveinsight.com/report-store/maple-syrup-urine-disease-market
MELAS Syndrome Market
https://www.delveinsight.com/report-store/melas-syndrome-market
Contact Info:
Shruti Thakur
Manager - Marketing & International Branding
Email: info@delveinsight.com
428, D21 Corporate Park, Sector-21, Dwarka, New Delhi-110077, India
About DelveInsight
DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Primary Open Angle Glaucoma (POAG) Pipeline Analysis (2023) Covering Clinical Trials, Emerging Therapies, FDA, EMA, and PMDA Approvals, Competitive Landscape | Santen, PH PHARMA, Whitecap Biosciences, Ocular Therapeutix, TheratOcular Biotek here
News-ID: 3288887 • Views: …
More Releases from DelveInsight Business Research LLP
Myelofibrosis Pipeline Report 2025 by DelveInsight: Key Insights into Clinical S …
DelveInsight's "Myelofibrosis Pipeline Insight" report provides comprehensive insights about 35+ companies and 40+ pipeline drugs in the Myelofibrosis pipeline landscape. It covers the Myelofibrosis pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Myelofibrosis therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Stay ahead with the latest insights! Download DelveInsight's comprehensive Myelofibrosis…
Hemophilia Pipeline Landscape Report 2025: DelveInsight's Exclusive Report on Cu …
DelveInsight's "Hemophilia Pipeline Insight" report provides comprehensive insights about 80+ companies and 80+ pipeline drugs in the Hemophilia pipeline landscape. It covers the Hemophilia pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Hemophilia therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Stay ahead with the latest insights! Download DelveInsight's comprehensive Hemophilia…
DelveInsight's NMIBC Pipeline 2025: Unveiling Drug Development Progress, Clinica …
DelveInsight's, "Non Muscle Invasive Bladder Cancer Pipeline Insight" report provides comprehensive insights about 20+ companies and 22+ pipeline drugs in Non Muscle Invasive Bladder Cancer pipeline landscape. It covers the Non Muscle Invasive Bladder Cancer pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Non Muscle Invasive Bladder Cancer therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive…
Hearing Loss Pipeline 2025 by DelveInsight: Exploring Novel Mechanisms of Action …
DelveInsight's "Hearing Loss Pipeline Insight" report provides comprehensive insights about 32+ companies and 35+ pipeline drugs in Hthe earing Loss pipeline landscape. It covers the Hearing Loss pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Hearing Loss therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Stay ahead with the latest insights!…
More Releases for Primary
Premier Primary Care Medicine Recognized as Top-Rated Primary Care Physician in …
Premier Primary Care Medicine has been recognized as the top-rated primary care physician in Marietta, Georgia. The designation highlights the practice's commitment to accessible, high-quality primary care, same-day and next-day appointments, and an approach centered on long-term patient relationships.
Marietta, GA - September 16, 2025 - Premier Primary Care Medicine [https://www.premierpcmed.com/] has been recognized as the top-rated primary care physician in Marietta, Georgia. The designation highlights the practice's commitment to accessible,…
Direct Primary Care Market
Direct Primary Care Market Worth 80.4 Bn 2031- Exclusive Report by InsightAce Analytic Pvt. Ltd.
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Direct Primary Care Market"- By Type (Clinical Services, Telehealth Services, Laboratory Services, Consultative Services), Care Setting (Office-Based DPC Practices, Home-Based DPC Practices, Telehealth-Only DPC Practices, Hybrid DPC Practices), End Users (Individuals, Employers, Small Businesses, Large Corporations, Insurance Companies (offering DPC as…
Primary Sclerosing Cholangitis Market
Primary Sclerosing Cholangitis (PSC) is a rare, chronic liver disease characterized by inflammation and scarring of the bile ducts, leading to liver damage and, ultimately, liver failure. The disease progresses slowly and often goes unnoticed in its early stages. Although the exact cause of PSC remains unknown, it is commonly associated with other inflammatory bowel diseases, particularly ulcerative colitis. The management of PSC includes symptom control, slowing disease progression, and…
Primary Healthcare Conference 2023
3rd World Congress on Primary Healthcare and Medicare Summit
Mercure Roma West, Viale degli Eroi di Cefalonia, 301, 00128 Rome, Italy
Email primaryhealthcare@pulsusgathering.org
On behalf of the Conference Organizing Committee, we would like to invite all of you for the "3rd Word Congress on Primary Healthcare and Medicare", which is going to be held in Rome, Italy on September 21-23, 2023. Primary Healthcare 2023 focuses on the basic theme "To Manifest the Multimorbidity…
Primary Lithium Battery (Primary Lithium Batteries) Market Key Companies and Ana …
The global lithium primary batteries market size will grow from $2.83 billion in 2022 to $2.9 billion in 2023 at a compound annual growth rate (CAGR) of 2.5%
Global " Primary Lithium Battery (Primary Lithium Batteries) Market" 2022 Reports give a Key study on the industry status of the Primary Lithium Battery (Primary Lithium Batteries) Manufacturer with the specific statistics, meaning, definition, SWOT Analysis, expert opinion, and recent development across…
Primary Prevention of Cancer
Primary prevention of cancer aims to prevent the disease before it ever occurs. More than 4 in 10 cancers as well as cancer deaths are linked to modifiable risk factors that can be altered as part of primary cancer prevention. The modifiable risk factors for primary prevention include:
1. Cigarette smoking: Smoking causes almost all cases of lung cancer and accounts for 30% of all cancer deaths. Prevention strategy for this risk…
